MarketCapExport financials
SCWorx Corp. (WORX)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
SCWorx Corp. Balance Sheet 2025-2011 | WORX
Brief overview of SCWorx Corp.'s financial position
The balance sheet is assessed across five available annual reports spanning 2021 to 2025.
Assets declined from $9.1 million to $7.9 million, or -13.4%. The contraction calls for context such as disposals, restructuring or weaker operations.
Liability growth of -72.6% trailed asset growth of -13.4%. The funding structure became more resilient.
Internal capital represents 90.6% of the balance sheet, previously 70.2%. This is a strong capital position.
The cash reserve occupies 20.8% of the balance sheet, previously 0.8%. It is one marker of short-term resilience.
The balance sheet carries negative retained earnings of -$35.4 million. The figure may result from accumulated losses or an active capital return policy.
What the balance sheet shows
SCWorx Corp.'s balance sheet is broadly resilient, though selected areas require monitoring. The balance between assets, equity and liabilities remains the key issue.
Annual Balance Sheet SCWorx Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | - | - | -376 K | -488 K | 1.4 M | -48.2 K | -4.68 M | 353 K | - | - | - | - |
Total Non Current Liabilities |
- | 19.7 K | 90.4 K | 148 K | 434 K | - | - | - | 23.9 K | - | - | - | - | - | - |
Total Current Liabilities |
744 K | 1.84 M | 2.33 M | 2.32 M | 2.28 M | 4.6 M | 3.07 M | 8.57 M | 1.6 M | 284 K | - | - | - | - | - |
Total Liabilities |
744 K | 1.86 M | 2.42 M | 2.47 M | 2.72 M | 4.89 M | 3.07 M | 8.57 M | 1.62 M | 284 K | 406 K | - | - | - | - |
Deferred Revenue |
159 K | 354 K | 379 K | 580 K | 473 K | 2.03 M | 1.06 M | - | 56.7 K | - | - | - | - | - | - |
Retained Earnings |
-35.4 M | -31 M | -29.8 M | -25.9 M | -24 M | - | -12.8 M | -31.3 M | -16.5 M | -4.55 M | -386 K | - | - | - | - |
Total Assets |
7.9 M | 6.35 M | 6.28 M | 9.25 M | 9.12 M | 10.6 M | 9.99 M | 5.66 M | 9.76 M | 14 M | 25 K | - | - | - | - |
Cash and Cash Equivalents |
1.64 M | 107 K | 91.4 K | 249 K | 71.1 K | 376 K | 488 K | 76.5 K | 42.8 K | 4.68 M | - | - | - | - | - |
Book Value |
7.15 M | 4.49 M | 3.85 M | 6.78 M | 6.41 M | 5.73 M | 6.93 M | -2.91 M | 8.13 M | 13.7 M | -381 K | - | - | - | - |
Total Shareholders Equity |
7.15 M | 4.49 M | 3.85 M | 6.78 M | 6.41 M | 5.73 M | 6.93 M | -232 K | 8.13 M | 13.7 M | -381 K | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Balance Sheet SCWorx Corp.
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | 2.11 K | 7.95 K | 7.04 K | 19.7 K | 7.11 K | - | - | 90.4 K | 99.9 K | 114 K | 129 K | 148 K | 154 K | 294 K | 294 K | 434 K | 434 K | 434 K | 434 K | 294 K | 294 K | 294 K | 294 K | - | - | - | - | 1.59 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
727 K | 1.18 M | 1.2 M | 1.56 M | 1.86 M | 2.04 M | 2.91 M | 2.64 M | 2.42 M | 2.66 M | 2.45 M | 2.75 M | 2.47 M | 2.48 M | 2.92 M | 3.14 M | 2.72 M | 3.75 M | 4.03 M | 4.87 M | 4.89 M | 4.89 M | 4.89 M | 4.89 M | 3.07 M | 3.07 M | 3.07 M | 2.3 M | 3.26 M | 3.26 M | 3.26 M | 3.26 M | 1.62 M | 1.62 M | 1.62 M | 1.62 M | 284 K | - | 284 K | 284 K | 406 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
158 K | 399 K | 219 K | 333 K | 354 K | 159 K | 388 K | 410 K | 379 K | 392 K | 586 K | 735 K | 580 K | 298 K | 589 K | 764 K | 473 K | 596 K | 921 K | 1.96 M | 2.03 M | 2.03 M | 2.03 M | 2.03 M | 1.06 M | 1.06 M | 1.06 M | 1.06 M | 817 K | 817 K | 817 K | 817 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-35.6 M | -34.7 M | -33.4 M | -31.5 M | -31 M | -30.8 M | -30.4 M | -30 M | -29.8 M | -27.3 M | -26.4 M | -26.3 M | -25.9 M | -25.6 M | -25.2 M | -24.6 M | -24 M | -23.2 M | -22.2 M | -20.9 M | -20.2 M | -20.2 M | -20.2 M | -20.2 M | -12.8 M | -12.8 M | -12.8 M | -12.8 M | -1.48 M | -1.48 M | -1.48 M | -1.48 M | -16.5 M | -16.5 M | -16.5 M | -16.5 M | -4.55 M | -4.55 M | -4.55 M | -4.55 M | -386 K | -386 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
7.78 M | 7.18 M | 6.65 M | 7.16 M | 6.35 M | 6.52 M | 6.51 M | 6.34 M | 6.28 M | 8.82 M | 9.05 M | 9.28 M | 9.25 M | 9.28 M | 9.06 M | 9.35 M | 9.12 M | 9.56 M | 9.39 M | 10.6 M | 10.6 M | 10.6 M | 10.6 M | 10.6 M | 9.99 M | 9.99 M | 9.99 M | 9.99 M | 3.03 M | 3.03 M | 3.03 M | 3.03 M | 9.76 M | 9.76 M | 9.76 M | 9.76 M | 14 M | 14 M | 14 M | 14 M | 25 K | 25 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
1.34 M | 684 K | 340 K | 1.07 M | 107 K | 87.7 K | 17.3 K | 39.6 K | 91.4 K | 72.4 K | 133 K | 250 K | 249 K | 362 K | 23.5 K | 8.29 K | 71.1 K | 402 K | 32.1 K | 89.1 K | 376 K | 376 K | 376 K | 376 K | 488 K | 488 K | 488 K | 488 K | 76.5 K | 76.5 K | 76.5 K | 76.5 K | 15.2 K | 42.8 K | 257 K | 348 K | 4.57 M | 4.68 M | 4.68 M | 4.68 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
7.05 M | 6 M | 5.45 M | 5.59 M | 4.49 M | 4.48 M | 3.61 M | 3.7 M | 3.85 M | 6.16 M | 6.59 M | 6.52 M | 6.78 M | 6.8 M | 6.15 M | 6.21 M | 6.41 M | 5.81 M | 5.35 M | 5.74 M | 5.73 M | 5.73 M | 5.73 M | 5.73 M | 6.93 M | 6.93 M | 6.93 M | 7.69 M | -232 K | -232 K | -232 K | -232 K | 8.13 M | 8.13 M | 8.13 M | 8.13 M | 13.7 M | 14 M | 13.7 M | 13.7 M | -381 K | 25 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
7.05 M | 6 M | 5.45 M | 5.59 M | 4.49 M | 4.48 M | 3.61 M | 3.7 M | 3.85 M | 6.16 M | 6.59 M | 6.52 M | 6.78 M | 6.8 M | 6.15 M | 6.21 M | 6.41 M | 5.81 M | 5.35 M | 5.74 M | 5.73 M | 5.73 M | 5.73 M | 5.73 M | 6.93 M | 6.93 M | 6.93 M | 6.93 M | -232 K | -232 K | -232 K | -232 K | -1.1 M | 8.13 M | 8.13 M | 8.13 M | 13.7 M | 13.7 M | 13.7 M | 13.7 M | -381 K | -381 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Balance Sheet is a fundamental financial report of SCWorx Corp., providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Health information services
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Signify Health
SGFY
|
- | -0.02 % | $ 7.21 B |  USA |
 |
Tabula Rasa HealthCare
TRHC
|
- | - | $ 255 M | USA |
 |
OptimizeRx Corporation
OPRX
|
$ 9.34 | -1.37 % | $ 173 M | USA |
 |
Change Healthcare
CHNG
|
- | - | $ 9.03 B | USA |
 |
Cerner Corporation
CERN
|
- | - | $ 27.9 B | USA |
 |
10x Genomics
TXG
|
$ 62.88 | -3.34 % | $ 7.84 B | USA |
 |
Veeva Systems
VEEV
|
$ 306.1 | -0.1 % | $ 50.1 B | USA |
 |
Zhongchao
ZCMD
|
$ 0.94 | -5.99 % | $ 3.21 M |  China |
 |
HealthStream
HSTM
|
$ 28.69 | -0.14 % | $ 861 M | USA |
 |
Accolade
ACCD
|
- | 0.29 % | $ 206 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
- | -10.39 % | $ 886 M | USA |
 |
NantHealth
NH
|
- | -46.64 % | $ 10.4 M | USA |
 |
Covetrus
CVET
|
- | - | $ 2.94 B | USA |
 |
NextGen Healthcare
NXGN
|
- | - | $ 1.6 B | USA |
 |
1Life Healthcare
ONEM
|
- | - | $ 3.37 B | USA |
 |
iCAD
ICAD
|
- | - | $ 102 M | USA |
 |
R1 RCM
RCM
|
- | - | $ 3.81 B | USA |
 |
So-Young International
SY
|
$ 2.0 | 0.5 % | $ 156 M | China |
 |
American Well Corporation
AMWL
|
$ 12.0 | -3.73 % | $ 193 M | USA |
 |
Evolent Health
EVH
|
$ 4.79 | 1.7 % | $ 547 M | USA |
 |
GoodRx Holdings
GDRX
|
$ 3.54 | -3.01 % | $ 1.26 B | USA |
 |
Castlight Health, Inc.
CSLT
|
- | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
- | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
- | - | $ 6.37 B | USA |
 |
Health Catalyst
HCAT
|
$ 1.46 | -3.31 % | $ 102 M | USA |
 |
HealthEquity
HQY
|
$ 103.68 | 1.53 % | $ 8.93 B | USA |
 |
Omnicell
OMCL
|
$ 35.87 | -3.96 % | $ 1.65 B | USA |
 |
Progyny
PGNY
|
$ 36.44 | 1.35 % | $ 3.11 B | USA |
 |
Schrödinger
SDGR
|
$ 32.42 | -2.89 % | $ 2.38 B | USA |
 |
Teladoc Health
TDOC
|
$ 8.96 | -0.28 % | $ 1.58 B | USA |
 |
Computer Programs and Systems
CPSI
|
- | 4.4 % | $ 133 M | USA |
 |
Phreesia
PHR
|
$ 13.15 | 1.94 % | $ 786 M | USA |
 |
Akerna Corp.
KERN
|
- | - | $ 161 M | USA |
 |
MTBC
MTBC
|
- | -0.58 % | $ 51.7 M | USA |
 |
Premier
PINC
|
- | - | $ 2.33 B | USA |
 |
Streamline Health Solutions
STRM
|
- | - | $ 21.4 M | USA |